At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 60 enrolled
Drug / intervention
0.25% Bupivacaine +1 moredrug
Likely dose
0.25% Bupivacaine 20 mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Periarticular Injection With Bupivacaine For Post-Operative Pain Control In Total Knee Replacement: A Prospective Randomized Double-Blind Controlled Trial
In Brief
A Phase 4 clinical trial evaluating 0.25% Bupivacaine and 0.9% normal saline for Pain, Postoperative and Arthropathy of Knee Joint. Completed, enrolled 60 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the efficacy of periarticular injection with 0.25% bupivacaine for controlling pain after total knee replacement to improve the quality of post-operative care.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Postoperative, Arthropathy of Knee Joint
CountriesThailand
CollaboratorsSiriraj Hospital
Timeline
Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2010
Primary CompletionSep 2010
First PostedJun 2011
TodayJul 2026
First PostedJun 2, 2011
Enrollment StartMar 1, 2010
Primary CompletionSep 1, 2010
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 15.1 years ago
Interventions
0.25% Bupivacainedrug
Periarticular injection with 20 ml of 0.25% bupivacaine before wound closure.
0.9% normal salinedrug
Periarticular injection with 20 ml of 0.9% normal saline before wound closure.